PIBIS: Implementation of the Pittsburgh Infant Brain Injury Score

Sponsor
University of Pittsburgh (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05034718
Collaborator
The Beckwith Institute (Other)
609
1
2
23.3
26.1

Study Details

Study Description

Brief Summary

This is an implementation study of the Pittsburgh Infant Brain Injury Score (PIBIS) into the UPMC Children's Hospital of Pittsburgh emergency department. Children less than 1 year of age presenting to the CHP ED for symptoms which place them at increased risk for AHT as defined in the PIBIS validation study will be potentially eligible.

Condition or Disease Intervention/Treatment Phase
  • Other: PIBIS clinical decision support
  • Other: Standard of care
N/A

Detailed Description

Abusive head trauma is the leading cause of death due to physical abuse. Missing the diagnosis of abusive head trauma (AHT), particularly when it less severe is common and contributes to increased morbidity and mortality. Over the past 10 years, the investigators have derived and subsequently prospectively validated the Pittsburgh Infant Brain Injury Score (PIBIS), a point of care clinical decision rule to help physicians determine when it is appropriate to obtain neuroimaging in infants who present to the ED for evaluation of soft neurologic signs such as vomiting and fussiness. The results of the NIH multi-center prospective validation were published in 2016 in Pediatrics.

The next step in evaluating PIBIS as a clinical prediction rule is to perform an implementation study. Children less than 1 year of age presenting to the CHP ED for symptoms which place them at increased risk for AHT as defined in the PIBIS validation study will be potentially eligible.

Discrete fields in the electronic health record - including patient age, Emergency Severity Index (ESI), Glasgow Coma Scale (GCS) score, temperature and chief complaint - will be used to identify potentially eligible children in a systematic and efficient manner. Children who are potentially eligible based on this initial screen will trigger an alert to the nurse who will then complete a brief powerform to ensure eligibility and assess for inclusion/exclusion criteria. Due to the nature of the research, the investigators will seek a waiver of informed consent as has been done in similar studies at our institution and others. At this point, eligible children will be considered enrolled.

For children enrolled during the intervention period, providers will be presented with a detailed decision support strategy which encourages - but does not require - use of the PIBIS to make clinical decision re: the need for neuroimaging. For children enrolled during the control period, no other clinical decision support will occur. The duration of this evaluation period will be 24 months.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
609 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Implementation of the Pittsburgh Infant Brain Injury Score
Actual Study Start Date :
Jul 5, 2021
Anticipated Primary Completion Date :
Jun 15, 2023
Anticipated Study Completion Date :
Jun 15, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Control Arm

Completion of nurse powerform and data collection only.

Other: Standard of care
Standard of care, absent the PIBIS powerform and alert for providers.

Experimental: Intervention Arm

Completion of nurse powerform, data collection and physician alert/powerform with score calculation and recommendations.

Other: PIBIS clinical decision support
The intervention is the presence of the PIBIS physician alert and powerform, which is clinical decision support for the treating provider if a patient meets inclusion criteria for Pittsburgh Infant Brain Injury Score (PIBIS) calculation.

Outcome Measures

Primary Outcome Measures

  1. Eligibility confirmation [From enrollment to hospital discharge, up to one month]

    Children identified as eligible by Cerner and confirmed by the nurse powerform as eligible for PIBIS will also be determined to be eligible after chart review and discussion with the clinician (which is how eligibility was determined during the validation study). The primary outcome will be the concordance between these two methods of determining eligibility. A concordance of >90% is the goal.

  2. Proportion of children with PIBIS calculation and recommendations [From enrollment to hospital discharge, up to one month]

    The proportion of children eligible for PIBIS who have a PIBIS score calculated and in whom the provider follows the recommendation by PIBIS OR documents in the EHR the clinical reasoning why they are NOT following the recommendation (e.g. patient being admitted, in-patient team will make decision).

Secondary Outcome Measures

  1. Proportion of children who undergo neuroimaging (head CT or brain MRI) during the control and intervention periods [From enrollment to hospital discharge, up to one month]

    The proportion of children eligible for PIBIS who undergo neuroimaging (head CT or brain MRI) during the control and intervention periods

  2. Proportion of neuroimaging which demonstrates an abnormality during the control and intervention periods [From enrollment to hospital discharge, up to one month]

    Proportion of neuroimaging which demonstrates an abnormality during the control and intervention periods

  3. Proportion of all children with each PIBIS score who are ultimately diagnosed with physical abuse by the CHP Child Protection Team [From enrollment to hospital discharge, up to one month]

    Proportion of all children with each PIBIS score who are ultimately diagnosed with physical abuse by the CHP Child Protection Team

  4. The number of enrolled children who return to the ED within 6 months of enrollment and undergo neuroimaging. [From enrollment to 6 months following hospital discharge]

    The number of enrolled children who return to the ED within 6 months of enrollment and undergo neuroimaging.

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Days to 364 Days
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 30 days to less than 1 year

  • Chief complaint of Apnea, BRUE, Fussiness or Irritability, Lethargy, Neurologic complaint, Poor Feeding-Acute, Seizures/Spells, or Vomiting Alone

  • First temperature in the ED less than or equal to 38.3C

  • Acuity level/ESI of 3, 4, or 5

Exclusion Criteria:
  • History of trauma related to this ED encounter

  • Parent reported temperature of greater than 38.3C in the prior 24 hours

  • Prior abnormal neuroimaging

  • Previously enrolled in this study within preceding 28 days

  • Provider preference for any reason

Contacts and Locations

Locations

Site City State Country Postal Code
1 UPMC Children's Hospital of Pittsburgh Pittsburgh Pennsylvania United States 15224

Sponsors and Collaborators

  • University of Pittsburgh
  • The Beckwith Institute

Investigators

  • Principal Investigator: Rachel Berger, MD, University of Pittsburgh

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Rachel Berger MD, MPH, Professor, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT05034718
Other Study ID Numbers:
  • STUDY21010197
First Posted:
Sep 5, 2021
Last Update Posted:
Jul 13, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 13, 2022